The Milwaukee-based Susan G. Komen Southeast Wisconsin will hold its Metastatic Breast Cancer Symposium on Thursday. The event is open to the public, and will take place at the GE Healthcare Institute in Waukesha from 1 p.m. to 4:30 p.m.
Dr. Ian Krop, an assistant professor of medicine at Harvard Medical School and the director of clinical research for the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute, will be the featured speaker.
Krop’s research is based around breast cancer treatment therapies and the study of HER-2 positive breast cancer. HER-2 positive breast cancer is one that tests positive for human epidermal growth factor receptor 2, which promotes the growth of cancer cells within the body. It is important to see if this cancer is present because it can significantly impact treatment recommendations and decisions.
Other speakers are Danny Welch from the University of Kansas Cancer Center and Shirley Mertz from the Metastatic Breast Cancer Network. Welch will speak on “New research on cancer metastasis — What we know and what we need to know.” Mertz will speak on “How patients can take charge of their treatment and be their own best advocate.”
For more information, click here.
